ABCL Competitors & Alternatives
Compare Abcellera Biologics Inc with similar stocks in the same industry
Biotechnology
ABCL
Main Stock$11.82
Tradestie Score
58
Market Cap
$1.78B
Revenue Growth
-0.8%
Analyst Upside
+42.3%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$84.95
|
$3.92B | - | 46 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$110.76
|
$3.91B | - | 49 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$24.03
|
$3.83B | - | 51 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$15.44
|
$3.68B | - | 44 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$80.39
|
$3.67B | - | 59 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$10.68
|
$3.59B | 15.6 | 38 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$19.73
|
$3.58B | 9.1 | 61 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$303.53
|
$3.49B | 32.4 | 50 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$9.15
|
$3.40B | 95.4 | 41 | Compare |
|
QURE
uniQure N.V.
|
$22.43
|
$3.39B | - | 63 | Compare |
More ABCL Analysis
Data updated: Oct 24, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry